Home/Filings/4/0001209191-21-059842
4//SEC Filing

Kayitalire Louis 4

Accession 0001209191-21-059842

CIK 0001566373other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 4:38 PM ET

Size

5.0 KB

Accession

0001209191-21-059842

Insider Transaction Report

Form 4
Period: 2021-10-04
Kayitalire Louis
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2021-10-04$7.23/sh64$46254,319 total
Footnotes (2)
  • [F1]Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
  • [F2]Includes 47,175 restricted stock units.

Issuer

F-star Therapeutics, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001831519

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:38 PM ET
Size
5.0 KB